NO20074825L - Piperidinylpiperazinderivater for anvendelse som inhibitorer av kjemokinreseptorer - Google Patents

Piperidinylpiperazinderivater for anvendelse som inhibitorer av kjemokinreseptorer

Info

Publication number
NO20074825L
NO20074825L NO20074825A NO20074825A NO20074825L NO 20074825 L NO20074825 L NO 20074825L NO 20074825 A NO20074825 A NO 20074825A NO 20074825 A NO20074825 A NO 20074825A NO 20074825 L NO20074825 L NO 20074825L
Authority
NO
Norway
Prior art keywords
compounds
inhibitors
compound
treatment
methods
Prior art date
Application number
NO20074825A
Other languages
English (en)
Norwegian (no)
Inventor
Stuart W Mccombie
Wenqing Feng
Tze-Ming Chan
Kathleen Cox
Michael W Miller
Daniel Weston
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36540289&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20074825(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20074825L publication Critical patent/NO20074825L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20074825A 2005-02-23 2007-09-21 Piperidinylpiperazinderivater for anvendelse som inhibitorer av kjemokinreseptorer NO20074825L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65557205P 2005-02-23 2005-02-23
PCT/US2006/006333 WO2006091692A1 (en) 2005-02-23 2006-02-21 Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors

Publications (1)

Publication Number Publication Date
NO20074825L true NO20074825L (no) 2007-10-17

Family

ID=36540289

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074825A NO20074825L (no) 2005-02-23 2007-09-21 Piperidinylpiperazinderivater for anvendelse som inhibitorer av kjemokinreseptorer

Country Status (17)

Country Link
US (1) US7659275B2 (de)
EP (1) EP1858887A1 (de)
JP (1) JP4769257B2 (de)
KR (1) KR20070107085A (de)
CN (1) CN101163695A (de)
AR (1) AR054740A1 (de)
AU (1) AU2006216731A1 (de)
BR (1) BRPI0609251A2 (de)
CA (1) CA2598651A1 (de)
IL (1) IL185395A0 (de)
MX (1) MX2007010258A (de)
NO (1) NO20074825L (de)
PE (1) PE20061012A1 (de)
RU (1) RU2411241C2 (de)
TW (1) TW200640910A (de)
WO (1) WO2006091692A1 (de)
ZA (1) ZA200707019B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA015517B1 (ru) 2004-04-13 2011-08-30 Инсайт Корпорейшн Производные пиперазинилпиперидина в качестве антагонистов хемокинового рецептора
RU2334515C2 (ru) * 2006-10-02 2008-09-27 ГОУ ВПО Военно-медицинская академия им. С.М. Кирова Применение "дневного" транквилизатора фенибута и антидепрессанта - селективного ингибитора обратного захвата серотонина триттико - при лечении псориаза
KR100861024B1 (ko) * 2007-07-20 2008-09-30 세크론 주식회사 반도체 제조 장치

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100439357B1 (ko) * 1999-05-04 2004-07-07 쉐링 코포레이션 Ｃｃｒ５ 길항제로서 유용한 피페리딘 유도체
US6391865B1 (en) * 1999-05-04 2002-05-21 Schering Corporation Piperazine derivatives useful as CCR5 antagonists
US6387930B1 (en) * 1999-05-04 2002-05-14 Schering Corporation Piperidine derivatives useful as CCR5 antagonists
US6689765B2 (en) * 1999-05-04 2004-02-10 Schering Corporation Piperazine derivatives useful as CCR5 antagonists
BR0010593A (pt) * 1999-05-04 2002-02-13 Schering Corp Terapia de combinação com antagonista de ccr5-interferon alfa peguilado para hiv
SK287418B6 (sk) * 1999-05-04 2010-09-07 Schering Corporation Farmaceutický prípravok s obsahom CCR5 antagonistov a súprava s obsahom tohto prípravku
AR033517A1 (es) * 2000-04-08 2003-12-26 Astrazeneca Ab Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos
JP4303969B2 (ja) * 2001-03-29 2009-07-29 シェーリング コーポレイション Ｃｃｒ５アンタゴニストとして有用なアリールオキシム−ピペラジン
AR033452A1 (es) * 2001-03-29 2003-12-17 Schering Corp Antagonistas de ccr5 utiles para el tratamiento del sida
GB0223223D0 (en) * 2002-10-07 2002-11-13 Novartis Ag Organic compounds
PE20040769A1 (es) * 2002-12-18 2004-11-06 Schering Corp Derivados de piperidina utiles como antagonisas ccr5
JO2525B1 (en) * 2004-04-08 2010-03-17 شركة جانسين فارماسوتيكا ان. في Derived 4-alkyl-and-4-canoelperidine derivatives and their use as anti-neroquin

Also Published As

Publication number Publication date
JP2008531575A (ja) 2008-08-14
RU2411241C2 (ru) 2011-02-10
PE20061012A1 (es) 2006-10-03
CN101163695A (zh) 2008-04-16
BRPI0609251A2 (pt) 2010-03-09
AR054740A1 (es) 2007-07-11
US7659275B2 (en) 2010-02-09
ZA200707019B (en) 2008-10-29
US20060223821A1 (en) 2006-10-05
WO2006091692A1 (en) 2006-08-31
CA2598651A1 (en) 2006-08-31
AU2006216731A1 (en) 2006-08-31
JP4769257B2 (ja) 2011-09-07
KR20070107085A (ko) 2007-11-06
IL185395A0 (en) 2008-02-09
MX2007010258A (es) 2007-09-11
RU2007135126A (ru) 2009-03-27
EP1858887A1 (de) 2007-11-28
TW200640910A (en) 2006-12-01

Similar Documents

Publication Publication Date Title
NO20090328L (no) Nye forbindelser 385
NO20090327L (no) Nye forbindelser 384
BR0310106A (pt) Composto, processo para a produção de um composto, composição farmacêutica, uso do composto e método para o tratamento de um sujeito em sofrimento de uma condição ou doença patalógica
Mallari et al. Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB
NO20082673L (no) Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens
SG170101A1 (en) 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
NO20084872L (no) 2-pyridonderivater for behandling av sykdom eller tilstander der inhibering av neutrofil elastaseaktivitet er gunstig
NO20073140L (no) Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser
MA35285B1 (fr) Indazoles
NO20064151L (no) Nye forbindelser
NO20075723L (no) Tiazolforbindelser og fremgangsmater for anvendelse
NO20074781L (no) 4-Oksokinazolin-3-ylbenzamidderivater for behandling av cytokinsykdommer
CN103842350B (zh) 作为dhodh抑制剂的五元二氢杂环酮类衍生物及应用
MXPA04001886A (es) Derivados de piperidina utiles como antagonistas de ccr5.
MX2024001417A (es) Compuestos de heteroarilo para tratar la enfermedad de huntington.
AU2016382372A1 (en) Sulfonamide derivative and preparation method and use thereof
WO2023244996A3 (en) Heterocyclic and heteroaryl compounds for treating huntington's disease
JP2012206959A (ja) グルコシダーゼ活性阻害用組成物及びそのスクリーニング方法
NO20074825L (no) Piperidinylpiperazinderivater for anvendelse som inhibitorer av kjemokinreseptorer
NO20083790L (no) Nye terapeutiske kombinasjoner for behandling eller forebygging av psykotiske lidelser
NO20051900L (no) Kinazolinderivater som SRC tyrosin kinase inhibitorer
EP0741569A1 (de) Naphtylisoquinolinalkaloiden, diese enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung zur Behandlung von Malaria
WO2008106125A3 (en) Deuterated derivatives of silodosin as alpha la-adrenoceptor antagonists
FR2869611A1 (fr) Derives de l'acide hexenoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
NO20091830L (no) Spiro-piperidinderivater som VIa reseptorantagonister

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application